CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 162 filers reported holding CARA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $62,244 | -38.3% | 37,052 | +3.9% | 0.00% | – |
Q2 2023 | $100,890 | -41.9% | 35,651 | +0.9% | 0.00% | – |
Q1 2023 | $173,528 | -55.3% | 35,347 | -2.1% | 0.00% | -100.0% |
Q4 2022 | $387,839 | +645.8% | 36,096 | +569.6% | 0.00% | – |
Q3 2022 | $52,000 | +2.0% | 5,391 | -3.7% | 0.00% | – |
Q2 2022 | $51,000 | -97.0% | 5,598 | -12.0% | 0.00% | -100.0% |
Q1 2022 | $1,713,000 | +2214.9% | 6,364 | +3.3% | 0.00% | – |
Q4 2021 | $74,000 | -21.3% | 6,163 | +0.8% | 0.00% | – |
Q3 2021 | $94,000 | +23.7% | 6,112 | +13.9% | 0.00% | – |
Q2 2021 | $76,000 | -52.5% | 5,366 | -27.3% | 0.00% | – |
Q1 2021 | $160,000 | +27.0% | 7,386 | -10.4% | 0.00% | – |
Q4 2020 | $126,000 | +14.5% | 8,246 | -4.6% | 0.00% | – |
Q3 2020 | $110,000 | -51.1% | 8,640 | -34.3% | 0.00% | -100.0% |
Q2 2020 | $225,000 | +8.7% | 13,147 | -16.5% | 0.00% | 0.0% |
Q1 2020 | $207,000 | – | 15,743 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chescapmanager LLC | 1,304,603 | $18,617,000 | 2.04% |
RHO CAPITAL PARTNERS INC | 1,499,058 | $21,392,000 | 1.96% |
DAFNA Capital Management LLC | 315,000 | $4,495,000 | 0.94% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 432,178 | $6,167,000 | 0.72% |
Altium Capital Management LP | 150,000 | $2,141,000 | 0.50% |
Cypress Capital Management LLC (WY) | 16,743 | $239,000 | 0.18% |
DISCIPLINED GROWTH INVESTORS INC /MN | 674,846 | $9,630,000 | 0.18% |
IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 73,902 | $1,055,000 | 0.16% |
FARALLON CAPITAL MANAGEMENT LLC | 2,000,000 | $28,540,000 | 0.12% |
FIRST QUADRANT LLC/CA | 71,223 | $1,016,000 | 0.12% |